Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Zealand Pharma A/S (ZEAL) stock

Learn how to easily invest in Zealand Pharma A/S stock.

Zealand Pharma A/S
-$0.34 (-1.12%)

Zealand Pharma A/S is a biotechnology business based in the US. Zealand Pharma A/S shares (ZEAL) are listed on the NASDAQ and all prices are listed in US Dollars. Zealand Pharma A/S employs 335 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Zealand Pharma A/S

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ZEAL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Zealand Pharma A/S stock price (NASDAQ: ZEAL)

Use our graph to track the performance of ZEAL stocks over time.

Zealand Pharma A/S shares at a glance

Information last updated 2021-07-23.
Latest market close$31.74
52-week range$27.90 - $44.42
50-day moving average $30.17
200-day moving average $32.14
Wall St. target price$39.13
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $3.00

Buy Zealand Pharma A/S shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Zealand Pharma A/S stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Zealand Pharma A/S price performance over time

Historical closes compared with the close of $31.74 from 2021-05-26

1 week (2021-07-12) N/A
1 month (2021-06-23) 10.94%
3 months (2021-04-19) N/A
6 months (2021-01-19) N/A
1 year (2020-07-19) N/A
2 years (2019-07-19) N/A
3 years (2018-07-19) N/A
5 years (2016-07-19) N/A

Zealand Pharma A/S financials

Revenue TTM $388.7 million
Gross profit TTM $262.7 million
Return on assets TTM -29.9%
Return on equity TTM -63.19%
Profit margin -233.95%
Book value $38.52
Market capitalisation $1.3 billion

TTM: trailing 12 months

Shorting Zealand Pharma A/S shares

There are currently 159,292 Zealand Pharma A/S shares held short by investors – that's known as Zealand Pharma A/S's "short interest". This figure is 0.2% down from 159,537 last month.

There are a few different ways that this level of interest in shorting Zealand Pharma A/S shares can be evaluated.

Zealand Pharma A/S's "short interest ratio" (SIR)

Zealand Pharma A/S's "short interest ratio" (SIR) is the quantity of Zealand Pharma A/S shares currently shorted divided by the average quantity of Zealand Pharma A/S shares traded daily (recently around 18267.431192661). Zealand Pharma A/S's SIR currently stands at 8.72. In other words for every 100,000 Zealand Pharma A/S shares traded daily on the market, roughly 8720 shares are currently held short.

However Zealand Pharma A/S's short interest can also be evaluated against the total number of Zealand Pharma A/S shares, or, against the total number of tradable Zealand Pharma A/S shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Zealand Pharma A/S's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Zealand Pharma A/S shares in existence, roughly 0 shares are currently held short) or 0.0044% of the tradable shares (for every 100,000 tradable Zealand Pharma A/S shares, roughly 4 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Zealand Pharma A/S.

Find out more about how you can short Zealand Pharma A/S stock.

Zealand Pharma A/S share dividends

We're not expecting Zealand Pharma A/S to pay a dividend over the next 12 months.

Zealand Pharma A/S share price volatility

Over the last 12 months, Zealand Pharma A/S's shares have ranged in value from as little as $27.9 up to $44.42. A popular way to gauge a stock's volatility is its "beta".

ZEAL.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Zealand Pharma A/S's is 0.8762. This would suggest that Zealand Pharma A/S's shares are less volatile than average (for this exchange).

Zealand Pharma A/S overview

Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes Dasiglucagon single use syringe or autoinjector that has completed Phase III clinical trials for the treatment of severe hypoglycemia; Dasiglucagon dual-hormone artificial pancreas has completed Phase II clinical trials for automated diabetes management; Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism and in Phase II clinical trials for post bariatric surgery hypoglycemia. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion; and Beta Bionics, Inc. The company was founded in 1997 and is headquartered in Copenhagen, Denmark.

Stocks similar to Zealand Pharma A/S

Frequently asked questions

What percentage of Zealand Pharma A/S is owned by institutions?
Currently 3.532% of Zealand Pharma A/S shares are held by institutions.
How many people work for Zealand Pharma A/S?
Latest data suggests 335 work at Zealand Pharma A/S.
When does the fiscal year end for Zealand Pharma A/S?
Zealand Pharma A/S's fiscal year ends in December.
Where is Zealand Pharma A/S based?
Zealand Pharma A/S's address is: Sydmarken 11, Copenhagen, Denmark, 2860
What is Zealand Pharma A/S's ISIN number?
Zealand Pharma A/S's international securities identification number is: US98920Y3045
What is Zealand Pharma A/S's CUSIP number?
Zealand Pharma A/S's Committee on Uniform Securities Identification Procedures number is: 98920Y304

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site